超极化13C-丙酮酸MRI在乳腺癌中的应用:综述
本综述汇总了超极化13C-MRI使用[1-13C]丙酮酸探针在乳腺癌临床前与临床研究中的文献。该技术可动态成像肿瘤代谢,利用Warburg效应显示瘤内[1-13C]丙酮酸蓄积并向[1-13C]乳酸转化。临床可行性已在乳腺癌患者中证实,高级别肿瘤中13C标记交换增加,并与MCT1表达升高和LDH相关;接受新辅助化疗患者的早期13C标记交换变化可能区分是否达到病理完全缓解(pCR)。
要点
- 超极化13C-MRI可动态显示[1-13C]丙酮酸在瘤内的分布及向[1-13C]乳酸的代谢转化。
- 乳腺癌患者中已证实临床可行性,高级别肿瘤的13C标记交换增加。
- 新辅助化疗早期13C标记交换变化可能区分是否达到pCR。
核心结论
- 超极化13C-MRI使用[1-13C]丙酮酸在乳腺癌中具有代谢表型分析和早期疗效评估的潜力,临床可行性已初步证实。
研究设计与样本
- 综述,汇总乳腺癌超极化13C-MRI使用[1-13C]丙酮酸的临床前与临床研究文献。
关键影像表现/征象
- 高级别乳腺癌中瘤内[1-13C]丙酮酸蓄积并向[1-13C]乳酸转化增加,表现为13C标记交换增加。
- 13C标记交换增加与单羧酸转运体1(MCT1)表达升高及乳酸脱氢酶(LDH)相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Tumour metabolism can be imaged with a novel imaging technique termed hyperpolarised carbon-13 (13C)-MRI using probes, i.e., endogenously found molecules that are labeled with 13C. Hyperpolarisation of the 13C label increases the sensitivity to a level that allows dynamic imaging of the distribution and metabolism of the probes. Dynamic imaging of [1-13C]pyruvate metabolism is of particular biological interest in cancer because of the Warburg effect resulting in the intratumoural accumulation of [1-13C]pyruvate and conversion to [1-13C]lactate. Numerous preclinical studies in breast cancer and other tumours have shown that hyperpolarised 13C-pyruvate has potential for metabolic phenotyping and response assessment at earlier timepoints than the current clinical imaging techniques allow. The clinical feasibility of hyperpolarised 13C-MRI after the injection of pyruvate in patients with breast cancer has now been demonstrated, with increased 13C-label exchange between pyruvate and lactate present in higher grade tumours with associated increased expression of the monocarboxylate transporter 1 (MCT1), the transmembrane transporter mediating intracellular pyruvate uptake, and lactate dehydrogenase (LDH) as the enzyme catalysing the conversion of pyruvate to lactate. Furthermore, a study in patients with breast cancer undergoing neoadjuvant chemotherapy suggested that early changes in 13C-label exchange can distinguish between patients who reach pathologic complete response (pCR) and those who do not. This review summarises the current literature on preclinical and clinical research on hyperpolarised 13C-MRI with [1-13C]-pyruvate in breast cancer imaging.
引用
- Arponen O, Wodtke P, Gallagher FA, et al. Hyperpolarised 13C-MRI using 13C-pyruvate in breast cancer: A review. Eur J Radiol. 2023. PMID: 37666071. doi:10.1016/j.ejrad.2023.111058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。